U.S. Markets open in 39 hrs, 51 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,309.92 | -154.48 | -1.48% |
| NASDAQ | 2,138.44 | -37.61 | -1.73% |
| S&P 500 | 1,091.49 | -19.14 | -1.72% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 8.45 09:30 AM EST | |
|---|---|---|
| Day High | 8.57 12:58 PM EST |
|
| Range | 0.12 |
| Volume | 81,934 | |
|---|---|---|
| 30-Day Avg Vol | 404,000 |
|
| Difference | -79.72% |
| Market Cap | 430.35 M | |
|---|---|---|
| Mkt Cap Chg | -1.00 M |
| Shares Out | 50.45 M | |
|---|---|---|
| % Shrs Traded | 0.16% | |
| 1yr EPS Est | -1.323 |
| 52-Wk Low | 4.39 | |
|---|---|---|
| 52-Wk High | 12.68 |
|
| Range | 8.29 |
| Prev Close | 8.55 11/25/09 | |
|---|---|---|
| Today's Open | 8.48 | |
| Change | -0.82% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 5.34 M |
| Revenue (LFY) | 0 | |
|---|---|---|
| Earnings (LFY) | -57.10 M | |
| Earnings (MRQ) | -11.44 M | |
| Next Earn Est | -0.339 | |
| Next Earnings | 03/08/2010 |
|
| EPS (TTM) | -1.00 | |
| 1yr EPS Growth | -30.99% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -6.00 | |
| PEG Ratio | — | |
| Return on Equity | -186.00 | |
| Beta | 1.72 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Cadence Pharmaceuticals follows the rhythm of hospitals' medical needs. The biopharmaceutical company develops drug candidates primarily for use in a hospital setting. The company licenses rights to compounds ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.339 3/8/10 | — — |
—
—
|
| Last Quarter | -0.268 9/30/09 | -0.23 9/30/09 |
0.038
Beat
|
| 2 Quarters Ago | -0.214 6/30/09 | -0.17 6/30/09 |
0.044
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 0.00 | 0.00 |
| Gross Profit | — | -529,646.00 |
| Operating Income | -11.29 M | -54.15 M |
| Net Income | -11.44 M | -57.10 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts